These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 16104992

  • 1. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
    Rivera A, Rebollo M, Sánchez F, Navarro F, Miró E, Mirelis B, Coll P.
    Clin Microbiol Infect; 2005 Sep; 11(9):759-61. PubMed ID: 16104992
    [Abstract] [Full Text] [Related]

  • 2. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S, Van Heirstraeten L, Lammens C, Chapelle S, Goossens H.
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [Abstract] [Full Text] [Related]

  • 3. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
    Alonso R, Mateo E, Ezpeleta G, Cisterna R.
    Int J Antimicrob Agents; 2007 Aug; 30(2):183-5. PubMed ID: 17543504
    [Abstract] [Full Text] [Related]

  • 4. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
    Albertí S, Cortés G, García-Rey C, Rubio C, Baquero F, García-Rodríguez JA, Bouza E, Aguilar L.
    Antimicrob Agents Chemother; 2005 Jan; 49(1):418-20. PubMed ID: 15616324
    [Abstract] [Full Text] [Related]

  • 5. Fluoroquinolone resistance in Streptococcus pyogenes.
    Richter SS, Diekema DJ, Heilmann KP, Almer LS, Shortridge VD, Zeitler R, Flamm RK, Doern GV.
    Clin Infect Dis; 2003 Feb 01; 36(3):380-3. PubMed ID: 12539083
    [Abstract] [Full Text] [Related]

  • 6. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
    Smeesters PR, Vergison A, Junior DC, Van Melderen L.
    Int J Antimicrob Agents; 2009 Jul 01; 34(1):44-9. PubMed ID: 19269141
    [Abstract] [Full Text] [Related]

  • 7. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N.
    J Antimicrob Chemother; 2007 Jan 01; 59(1):28-34. PubMed ID: 17065188
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany.
    Reinert RR, Lütticken R, Al-Lahham A.
    Clin Microbiol Infect; 2004 Jul 01; 10(7):659-62. PubMed ID: 15214881
    [Abstract] [Full Text] [Related]

  • 11. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
    Van Heirstraeten L, Leten G, Lammens C, Goossens H, Malhotra-Kumar S.
    J Antimicrob Chemother; 2012 Nov 01; 67(11):2602-5. PubMed ID: 22815354
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec 01; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 13. Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.
    Pletz MW, McGee L, Van Beneden CA, Petit S, Bardsley M, Barlow M, Klugman KP.
    Antimicrob Agents Chemother; 2006 Mar 01; 50(3):943-8. PubMed ID: 16495255
    [Abstract] [Full Text] [Related]

  • 14. Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
    Pires R, Ardanuy C, Rolo D, Morais A, Brito-Avô A, Gonçalo-Marques J, Liñares J, Santos-Sanches I.
    Antimicrob Agents Chemother; 2010 Jun 01; 54(6):2677-80. PubMed ID: 20350943
    [Abstract] [Full Text] [Related]

  • 15. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
    Arai K, Hirakata Y, Yano H, Kanamori H, Endo S, Hirotani A, Abe Y, Nagasawa M, Kitagawa M, Aoyagi T, Hatta M, Yamada M, Nishimaki K, Takayama Y, Yamamoto N, Kunishima H, Kaku M.
    J Antimicrob Chemother; 2011 Mar 01; 66(3):494-8. PubMed ID: 21172783
    [Abstract] [Full Text] [Related]

  • 16. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct 01; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 17. Distribution of emm types among group A streptococcal isolates from Serbia.
    Mijac V, Ranin L, Marković M, Heeg C, Reinert RR, Opavski N.
    Clin Microbiol Infect; 2010 Mar 01; 16(3):295-8. PubMed ID: 19519840
    [Abstract] [Full Text] [Related]

  • 18. Linkage of ciprofloxacin resistance with a single genotypic cluster of Klebsiella pneumoniae.
    Dashti AA, Paton R, Amyes SG.
    Int J Antimicrob Agents; 2006 Jan 01; 27(1):73-6. PubMed ID: 16321509
    [Abstract] [Full Text] [Related]

  • 19. Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.
    Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M, Mirelis B, Coll P.
    J Med Microbiol; 2006 Aug 01; 55(Pt 8):1115-1123. PubMed ID: 16849733
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY, Pillay B, Pillay D.
    J Antimicrob Chemother; 2006 Dec 01; 58(6):1274-8. PubMed ID: 17040923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.